4. Economic impact of overall expenditure on liver cancer patient’s family.
| Variables | Expenditure of newly diagnosed course/Annual expenditure of illness* (CNY) (N=2,175) | Self-reported predicted reimbursement ratio (%) (N=2,175) | Out-of-pocket expenditure**(A) (CNY) (N=2,175) | Previous year household income (N=2,153 ) | Self-reported degree of economic
pressure (%) (N=2,210) |
||||||
| Amount (B) (CNY) | Ratio (A/B) | Not at all | Somewhat but manageable | Heavy | Overwhelmed | P*** | |||||
| *, The 12-month duration covers 2 months before and 10 months after the diagnosis; **, Out-of-pocket expenditure=(∑(1 − Self-reported predicted reimbursement ratio) × Medical expenditure of newly diagnosed course + Non-medical expenditure of newly diagnosed course)/n; ***, Chi-square tests; CNY, Chinese Yuan. | |||||||||||
| Total | 46,070 | 46.9 | 24,953 | 56,468 | 0.4 | 7.8 | 15.0 | 31.4 | 45.8 | − | |
| Hospital type | |||||||||||
| General | 38,207 | 57.5 | 18,562 | 73,501 | 0.3 | 12.8 | 20.0 | 32.9 | 34.4 | <0.001 | |
| Specialized | 48,611 | 43.3 | 27,074 | 50,961 | 0.5 | 6.2 | 13.4 | 31.0 | 49.5 | ||
| Age at diagnosis (year) | |||||||||||
| <45 | 51,019 | 43.2 | 29,796 | 62,202 | 0.5 | 6.4 | 11.7 | 31.1 | 50.8 | <0.001 | |
| 45−54 | 46,775 | 44.3 | 26,440 | 56,066 | 0.5 | 5.3 | 15.4 | 29.5 | 49.8 | ||
| 55−64 | 45,170 | 48.5 | 24,050 | 54,510 | 0.4 | 8.0 | 14.3 | 32.8 | 44.9 | ||
| ≥65 | 42,824 | 50.5 | 20,660 | 55,676 | 0.4 | 11.9 | 17.9 | 32.2 | 38.0 | ||
| Gender | |||||||||||
| Male | 46,569 | 46.7 | 25,183 | 56,622 | 0.4 | 7.9 | 14.6 | 31.5 | 45.9 | 0.800 | |
| Female | 44,171 | 47.4 | 24,065 | 55,873 | 0.4 | 7.2 | 16.3 | 31.3 | 45.2 | ||
| Education | |||||||||||
| Primary school or below | 40,974 | 41.4 | 23,906 | 43,198 | 0.6 | 6.3 | 11.0 | 32.7 | 50.0 | <0.001 | |
| Junior high school | 42,973 | 44.2 | 24,388 | 54,542 | 0.4 | 5.2 | 16.2 | 32.5 | 46.1 | ||
| Senior high school | 49,755 | 52.0 | 25,614 | 63,641 | 0.4 | 10.9 | 15.5 | 29.1 | 44.5 | ||
| Undergraduate or over | 64,114 | 61.2 | 28,879 | 85,523 | 0.3 | 14.1 | 21.4 | 29.6 | 35.0 | ||
| Occupation | |||||||||||
| Farmer | 41,180 | 36.1 | 26,514 | 41,770 | 0.6 | 2.0 | 8.4 | 33.4 | 56.2 | <0.001 | |
| Enterprise or company
employee/worker |
45,802 | 56.1 | 21,044 | 62,700 | 0.3 | 13.6 | 20.0 | 27.7 | 38.7 | ||
| Self-employed or
unemployed |
46,555 | 41.6 | 27,577 | 72,497 | 0.4 | 8.0 | 15.1 | 30.9 | 46.0 | ||
| Retiree | 54,054 | 60.7 | 25,236 | 67,599 | 0.4 | 15.0 | 20.1 | 29.5 | 35.5 | ||
| Staff in institution/civil
servant |
60,834 | 64.6 | 24,240 | 68,698 | 0.4 | 9.2 | 26.6 | 31.8 | 32.4 | ||
| Other | 45,245 | 42.7 | 26,482 | 56,242 | 0.5 | 3.0 | 9.1 | 60.6 | 27.3 | ||
| Health-care insurance type | |||||||||||
| Urban employees basic
medical insurance |
49,419 | 58.6 | 22,234 | 64,584 | 0.3 | 14.6 | 18.5 | 27.3 | 39.6 | <0.001 | |
| Urban residents basic
medical insurance |
47,668 | 49.8 | 23,591 | 60,320 | 0.4 | 6.0 | 18.8 | 33.8 | 41.4 | ||
| New rural cooperative
medical scheme |
42,510 | 36.8 | 27,571 | 44,620 | 0.6 | 1.9 | 9.6 | 33.6 | 54.8 | ||
| Commercial insurance | 22,221 | 10.6 | 20,336 | 46,842 | 0.4 | 5.3 | 5.3 | 36.8 | 52.6 | ||
| Self-financed | 41,799 | 0.0 | 41,799 | 104,514 | 0.4 | 7.5 | 22.5 | 40.0 | 30.0 | ||
| Other | 59,682 | 69.9 | 20,257 | 72,136 | 0.3 | 13.6 | 18.2 | 40.9 | 27.3 | ||
| Previous year household income (CNY) | |||||||||||
| <20,000 | 39,281 | 38.0 | 24,624 | 10,888 | 2.3 | 0.4 | 4.9 | 20.6 | 74.1 | <0.001 | |
| 20,000−39,999 | 44,199 | 42.0 | 26,124 | 26,983 | 1.0 | 2.7 | 8.1 | 31.6 | 57.6 | ||
| 40,000−69,999 | 45,246 | 46.9 | 24,011 | 50,150 | 0.5 | 8.1 | 16.6 | 31.0 | 44.2 | ||
| ≥70,000 | 51,529 | 55.5 | 25,012 | 108,404 | 0.2 | 15.0 | 24.3 | 35.3 | 25.4 | ||
| Clinical stage | |||||||||||
| I | 45,032 | 48.0 | 23,118 | 57,594 | 0.4 | 5.7 | 15.8 | 28.3 | 50.2 | 0.004 | |
| II | 44,479 | 47.9 | 24,062 | 53,461 | 0.5 | 6.5 | 15.5 | 26.0 | 51.9 | ||
| III | 44,573 | 44.6 | 24,592 | 54,950 | 0.5 | 9.0 | 13.7 | 34.9 | 42.5 | ||
| IV | 45,446 | 48.1 | 25,102 | 61,929 | 0.4 | 7.2 | 17.3 | 29.9 | 45.6 | ||
| Therapeutic regimen | |||||||||||
| Surgery | 59,301 | 47.0 | 32,520 | 61,581 | 0.5 | 8.5 | 14.2 | 36.9 | 40.4 | 0.005 | |
| Chemotherapy | 42,480 | 50.3 | 21,726 | 59,854 | 0.4 | 9.4 | 15.9 | 25.3 | 49.4 | ||
| Surgery and postoperative
chemotherapy |
52,035 | 48.5 | 27,420 | 60,440 | 0.5 | 2.4 | 17.3 | 40.2 | 40.2 | ||
| Symptomatic treatment | 41,113 | 44.5 | 22,958 | 53,408 | 0.4 | 8.26 | 14.65 | 30.68 | 46.4 | ||
| Concurrent
chemoradiotherapy |
52,664 | 39.1 | 35,458 | 59,800 | 0.6 | 15.8 | 26.3 | 36.8 | 21.1 | ||
| Radiotherapy | 49,076 | 52.7 | 24,359 | 54,040 | 0.5 | 6.3 | 21.9 | 25.0 | 46.9 | ||
| Neoadjuvant
chemoradiotherapy and surgery |
44,756 | 56.5 | 23,002 | 61,135 | 0.4 | 0.00 | 18.2 | 45.5 | 36.4 | ||
| Pathological type | |||||||||||
| Hepatocellular carcinoma | 48,150 | 48.1 | 25,896 | 56,536 | 0.5 | 5.2 | 15.2 | 30.5 | 49.1 | <0.001 | |
| Other | 47,567 | 50.2 | 23,787 | 69,449 | 0.3 | 21.5 | 22.3 | 36.5 | 19.7 | ||